Browsing 15 ePresentations
Interdisciplinary Network Relevance- PVD
Filtered By
- PVD
Sort By
PULMONARY HYPERTENSION (PH) -> PH - Other
Abstracts
12 - Results from the REPAIR Study: Effects of Macitentan on Right Ventricular (RV) Remodelling in Pulmonary Arterial Hypertension (PAH)
Presentation Number
12
Session Name
SESSION 05 - ORAL: Pulmonary Hypertension: Where We're Going We Don't Need Roads
Date
Wed, Apr 22, 2020
Time
10:30 AM - 12:15 PM
Authors
- A. Vonk Noordegraaf, Amsterdam, Netherlands
- R. Channick, Los Angeles, CA, United States of America
- E. Cottreel, Allschwil, Switzerland
- D. Kiely, Sheffield, United Kingdom
- N. Martin, Allschwil, Switzerland
- O. Moiseeva, St Petersburg, Russian Federation
- A. Peacock, Glasgow, United Kingdom
- A. Tawakol, Boston, MA, United States of America
- A. Torbicki, Otwock, Poland
- S. Rosenkranz, Cologne, Germany
- N. Galiè, Bologna, Italy
Late Breaking Clinical Science
Abstracts
14 - INSPIRE: Final Results from a Phase 3, Open-Label, Pivotal Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension
Presentation Number
14
Session Name
SESSION 05 - ORAL: Pulmonary Hypertension: Where We're Going We Don't Need Roads
Date
Wed, Apr 22, 2020
Time
10:30 AM - 12:15 PM
Authors
- N. Hill, Boston, MA, United States of America
- J. Feldman, Phoenix, AZ, United States of America
- S. Sahay, Houston, TX, United States of America
- D. Levine, San Antonio, TX, United States of America
- R. Roscigno, Morrisville, NC, United States of America
- T. Vaughn, Morrisville, NC, United States of America
- T. Bull, Aurora, CO, United States of America
PULMONARY HYPERTENSION (PH) -> PH - Pulmonary Arterial Hypertension
Abstracts
16 - Validation of REVEAL Risk Score Calculator 2.0 in Patients with PAH in the Phase III PATENT Study
Presentation Number
16
Session Name
SESSION 05 - ORAL: Pulmonary Hypertension: Where We're Going We Don't Need Roads
Date
Wed, Apr 22, 2020
Time
10:30 AM - 12:15 PM
Authors
- R. Benza, Columbus, OH, United States of America
- H. Farber, Boston, MA, United States of America
- A. Frost, Houston, TX, United States of America
- H. Ghofrani, Glessen, Germany
- P. Corris, Newcastle upon Tyne, United Kingdom
- B. Brockmann, Essen, Germany
- S. Nikkho, Berlin, Germany
- C. Meier, Berlin, Germany
- M. Hoeper, Hannover, Germany
PULMONARY HYPERTENSION (PH) -> PH - Physiology/RV Failure/Complications
Abstracts
18 - Right Atrial Pacing to Improve Acute Hemodynamics in Pulmonary Arterial Hypertension
Presentation Number
18
Session Name
SESSION 05 - ORAL: Pulmonary Hypertension: Where We're Going We Don't Need Roads
Date
Wed, Apr 22, 2020
Time
10:30 AM - 12:15 PM
Authors
- J. Khural, Charleston, SC, United States of America
- B. Houston, Charleston, SC, United States of America
- P. Leary, Seattle, WA, United States of America
- S. Mathai, Baltimore, MD, United States of America
- T. Kolb, Baltimore, MD, United States of America
- R. Damico, Baltimore, MD, United States of America
- H. Paul, Baltimore, MD, United States of America
- D. Kass, Baltimore, MD, United States of America
- S. Hsu, Baltimore, MD, United States of America
- R. Tedford, Charleston, SC, United States of America
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) -> CTEPH - Chronic Thromboembolic Pulmonary Hypertension
Abstracts
54 - Validation of REVEAL Risk Score Calculator 2.0 in Patients with CTEPH in the Phase III CHEST Study
Presentation Number
54
Session Name
SESSION 14 - ORAL: CTEPH - Connecting the Clots and Crossing the Dots
Date
Wed, Apr 22, 2020
Time
02:00 PM - 03:45 PM
Authors
- R. Benza, Columbus, OH, United States of America
- H. Farber, Boston, MA, United States of America
- A. Frost, Houston, TX, United States of America
- H. Ghofrani, Glessen, Germany
- P. Corris, Newcastle upon Tyne, United Kingdom
- B. Brockmann, Essen, Germany
- S. Nikkho, Berlin, Germany
- C. Meier, Berlin, Germany
- M. Hoeper, Hannover, Germany
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) -> CTEPH - Chronic Thromboembolic Pulmonary Hypertension
Abstracts
57 - Clinical Implications of Sarcopenia in Patients Undergoing Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertention
Presentation Number
57
Speakers
Session Name
SESSION 14 - ORAL: CTEPH - Connecting the Clots and Crossing the Dots
Date
Wed, Apr 22, 2020
Time
02:00 PM - 03:45 PM
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) -> CTEPH - Chronic Thromboembolic Pulmonary Hypertension
Abstracts
403 - Outcomes of Patients with Chronic Thromboembolic Pulmonary Hypertension Risk Stratified by a Dedicated Heart Team to Receive Pulmonary Endarectomy or Balloon Pulmonary Angiogiplasty
Presentation Number
403
Speakers
Session Name
MINI ORAL 05B - MINI ORAL SESSION: Pulmonary Hypertension
Date
Wed, Apr 22, 2020
Time
06:45 PM - 07:15 PM
Authors
- N. Bart, Sydney, Australia
- C. Ambati, Sydney, Australia
- K. Kearney, Darlinghurst, Australia
- S. Scheuer, Darlinghurst, Australia
- S. Emmanuel, Darlinghurst, Australia
- M. Wilson, Sydney, Australia
- A. Jabbour, Sydney, Australia
- C. Hayward, Sydney, Australia
- P. Macdonald, Sydney, Australia
- E. Kotlyar, Darlinghurst, Australia
- A. Keogh, Darlinghurst, Australia
- K. Dhital, Sydney, Australia
- D. Boshell, Sydney, Australia
- P. Jansz, Sydney, Australia
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) -> CTEPH - Chronic Thromboembolic Pulmonary Hypertension
Abstracts
1307 - Tricuspid Surgery and Pulmonary Thromboendarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension
Presentation Number
1307
Session Name
POSTER SESSION 3 - POSTER SESSION: Pulmonary Hypertension and CTEPH
Date
Fri, Apr 24, 2020
Time
06:00 PM - 07:15 PM
PULMONARY HYPERTENSION (PH) -> PH - Physiology/RV Failure/Complications
Abstracts
1308 - The Effect of Exercise on Endothelin 1 Level in Patients with Pulmonary Hypertension
Presentation Number
1308
Session Name
POSTER SESSION 3 - POSTER SESSION: Pulmonary Hypertension and CTEPH
Date
Fri, Apr 24, 2020
Time
06:00 PM - 07:15 PM
Authors
- A. Albulushi, Omaha, NE, United States of America
- K. Dhar, Omaha, NE, United States of America
- D. Stoller, Omaha, NE, United States of America
- M. Hyden, Omaha, NE, United States of America
- A. Burdorf, Omaha, NE, United States of America
- B. Lowes, Omaha, NE, United States of America
- R. Zolty, Omaha, NE, United States of America
PULMONARY HYPERTENSION (PH) -> PH - Pulmonary Arterial Hypertension
Abstracts
1310 - Treatment of Drug- and Toxin-Induced Pulmonary Arterial Hypertension (PAH): Real-World Experience with Macitentan
Presentation Number
1310
Session Name
POSTER SESSION 3 - POSTER SESSION: Pulmonary Hypertension and CTEPH
Date
Fri, Apr 24, 2020
Time
06:00 PM - 07:15 PM
Authors
- A. Ravichandran, Indianapolis, IN, United States of America
- R. Channick, Los Angeles, CA, United States of America
- K. Chin, Dallas, TX, United States of America
- V. McLaughlin, Ann Arbor, MI, United States of America
- R. Zamanian, Stanford, CA, United States of America
- M. Flynn, South San Francisco, CA, United States of America
- S. Leroy, Allschwil, Switzerland
- R. Ong, Allschwil, Switzerland
- G. Wetherill, Allschwil, Switzerland
- N. Kim, La Jolla, CA, United States of America
PULMONARY HYPERTENSION (PH) -> PH - Pulmonary Arterial Hypertension
Abstracts
1313 - Prognostic Significance of Echocardiographic Parameters in Predicting Early Decline in Patients with Pulmonary Arterial Hypertension
Presentation Number
1313
Session Name
POSTER SESSION 3 - POSTER SESSION: Pulmonary Hypertension and CTEPH
Date
Fri, Apr 24, 2020
Time
06:00 PM - 07:15 PM
PULMONARY HYPERTENSION (PH) -> PH - Pulmonary Arterial Hypertension
Abstracts
1314 - Adding Echocardiography of the Right Heart to Risk Assessment Scores in Prostanoid-Treated Pulmonary Arterial Hypertension
Presentation Number
1314
Speakers
Session Name
POSTER SESSION 3 - POSTER SESSION: Pulmonary Hypertension and CTEPH
Date
Fri, Apr 24, 2020
Time
06:00 PM - 07:15 PM
Authors
